🔑 Key Definitions
Neurotransmitter: Chemical messenger released at synapse that affects postsynaptic neuron
Synapse: Junction between two neurons consisting of presynaptic terminal, synaptic cleft, and postsynaptic membrane
Synaptic Cleft: Small gap (~20-40 nanometers) between presynaptic and postsynaptic neurons
Receptor: Protein molecule on postsynaptic membrane that binds specific neurotransmitters
Synapse: Junction between two neurons consisting of presynaptic terminal, synaptic cleft, and postsynaptic membrane
Synaptic Cleft: Small gap (~20-40 nanometers) between presynaptic and postsynaptic neurons
Receptor: Protein molecule on postsynaptic membrane that binds specific neurotransmitters
📅 Historical Breakthrough (1950s-1960s)
- Reserpine: Drug that depletes monoamines; caused depression-like symptoms in patients
- Chlorpromazine: First antipsychotic drug; blocks dopamine receptors; reduced schizophrenia symptoms
- LSD: Discovered to affect serotonin systems; demonstrated chemical basis of consciousness/perception
- Significance: These drugs proved that mental states depend on brain chemistry
🧠 Neurotransmitter Classification
- Monoamines: Dopamine, norepinephrine, serotonin (all derived from amino acids)
- Amino Acids: Glutamate (excitatory), GABA (inhibitory), glycine
- Acetylcholine: Cholinergic system; muscle contraction, arousal, memory
- Neuropeptides: Endorphins, substance P, neuropeptide Y
📊 Synapse Structure
- Presynaptic Terminal: Contains synaptic vesicles filled with neurotransmitter
- Synaptic Cleft: Extracellular space where neurotransmitter diffuses
- Postsynaptic Membrane: Contains receptors that bind neurotransmitter
💡 Exam Tips
- 1950s-60s drug discoveries = birth of psychopharmacology
- Remember: Reserpine depletes NTs (causes depression), Chlorpromazine blocks dopamine (treats schizophrenia)
- LSD affects serotonin - showed chemistry underlies perception
- Three main NT classes: monoamines, amino acids, acetylcholine
- Synapse has three parts: presynaptic, cleft, postsynaptic
- This era revolutionized treatment of mental illness